BlackRock, Inc. 13D and 13G filings for ShockWave Medical, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-24 2:27 pm Sale |
2023-12-31 | 13G | ShockWave Medical, Inc. SWAV |
BlackRock Inc. BLK |
3,740,596 10.100% |
-832,063 (-18.20%) |
Filing |
| 2023-01-23 3:52 pm Purchase |
2022-12-31 | 13G | ShockWave Medical, Inc. SWAV |
BlackRock Inc. BLK |
4,572,659 12.700% |
259,106 (+6.01%) |
Filing |
| 2022-07-08 4:56 pm Purchase |
2022-06-30 | 13G | ShockWave Medical, Inc. SWAV |
BlackRock Inc. BLK |
4,313,553 12.100% |
1,597,020 (+58.79%) |
Filing |
| 2022-02-03 4:41 pm Purchase |
2021-12-31 | 13G | ShockWave Medical, Inc. SWAV |
BlackRock Inc. BLK |
2,716,533 7.700% |
318,853 (+13.30%) |
Filing |
| 2021-02-02 3:13 pm Purchase |
2020-12-31 | 13G | ShockWave Medical, Inc. SWAV |
BlackRock Inc. BLK |
2,397,680 7.000% |
2,397,680 (New Position) |
Filing |